Nature

Development of inducible EIAV-based lentiviral vector packaging and producer cell lines

Large-scale production of gene therapeutics comprising equine infectious anaemia virus (EIAV) -based lentiviral vectors (LVs) would benefit from the development of producer cell lines enabling the ...
Business Wire

Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers

NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, today announced the acquisition of Quanta BioDesign, the inventor of discrete ...
FiercePharma

The tale of two companies: One viral vector partner for every stage of gene therapy development

Gene therapies can correct diseases at their genetic core, but their success hinges on viral vector manufacturing. As gene therapy technology becomes more advanced, producing viral vectors becomes ...
Nature

Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA

This work describes the development of a suitable gene transfer tool for future XLA gene therapy by improvement of the original CD19 promoter-based lentiviral vector by Eμmar sequence addition that ...